In this article, the author shares a first-hand, practical approach to breaking down FP&A silos and enabling true business agility through better alignment and collaboration.
Orli Shvartzman
Orli Shvartzman is a Boston-based strategic finance leader with nearly two decades of experience in financial planning and analysis (FP&A) across the healthcare sector, including roles at Inozyme Pharma, Lantheus Medical Imaging, BiOM (iWalk), Covidien (now Medtronic), and Boston Scientific.
She currently serves as the Head of Corporate FP&A at Balt, where she drives cross-functional alignment, financial strategy, and data-driven decision-making to support the organization's growth. Orli has deep expertise in scaling finance functions, ERP and EPM implementations, and leading financial planning from pre-clinical through commercial stages.
Her experience spans U.S. and international markets.
She is known for championing digital transformation, cross-cultural collaboration, and business partnerships at every level of the enterprise.
+
Subscribe to
FP&A Trends Digest
We will regularly update you on the latest trends and developments in FP&A. Take the opportunity to have articles written by finance thought leaders delivered directly to your inbox; watch compelling webinars; connect with like-minded professionals; and become a part of our global community.